title: Peritoneal dialysis adequacy: a model to assess feasibility with various modalities.
abstract: BACKGROUND
  The current standard of adequacy for peritoneal dialysis (PD) is to provide a weekly normalized urea clearance (Kt/V) of 2.0 or more and a creatinine clearance (CCr) of 60 liter/1.73 m2 or more. As native renal function is lost, it is important to determine the effectiveness of the available therapeutic modalities in achieving these goals.
  
  
  METHODS
  A model to assess our ability to provide a weekly Kt/Vurea of 2.0 or more and a CCr of 60 liter/1.73 m2 or more to anuric patients undergoing continuous ambulatory PD (CAPD) and automated PD (PD Plus) was developed. The body surface area (BSA) distribution was obtained from 38,768 patients undergoing dialysis during January 1997. The distribution of peritoneal transport rates (PTRs) was obtained from 2531 peritoneal equilibration tests performed during 1996. The weekly Kpt/Vurea was calculated for the various PTR groups and the range of BSA with four PD prescriptions: CAPD 8 liters, CAPD 10 liters, PD Plus 12 liters, and PD Plus 15 liters, using a previously validated kinetic program (PackPD).
  
  
  RESULTS
  The predicted percentage of patients capable of achieving the adequacy goals for Kt/V and CCr, respectively, were 24.8 and 11. 2 for CAPD 8 liters, 54.2 and 33.0 for CAPD 10 liters, 77.8 and 54.9 for PD Plus 12 liters, and 93.2 and 72.9 for PD Plus 15 liters.
  
  
  CONCLUSIONS
  Most patients can attain the current adequacy standards of therapy with automated PD, but few (less than 25%) can do so with standard CAPD in the absence of residual renal function.
authors.affiliation: Fresenius Medical Care North America, Lexington, Massachusetts, USA.
authors.forename: J A
authors.initials: JA
authors.lastname: Diaz-Buxo
authors.forename: F A
authors.initials: FA
authors.lastname: Gotch
authors.forename: T I
authors.initials: TI
authors.lastname: Folden
authors.forename: S
authors.initials: S
authors.lastname: Rosenblum
authors.forename: J
authors.initials: J
authors.lastname: Zazra
authors.forename: N
authors.initials: N
authors.lastname: Lew
authors.forename: T L
authors.initials: TL
authors.lastname: Crawford
authors.forename: B
authors.initials: B
authors.lastname: Youngblood
authors.forename: A
authors.initials: A
authors.lastname: Pesich
authors.forename: J M
authors.initials: JM
authors.lastname: Lazarus
mesh_terms: D001002:Anuria / Q000503:physiopathology / Q000628:therapy; D001693:Biological Transport, Active; D005260:Female; D006801:Humans; D007668:Kidney / Q000503:physiopathology; D008297:Male; D008954:Models, Biological; D010530:Peritoneal Dialysis / Q000379:methods*; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000379:methods; D010537:Peritoneum / Q000503:physiopathology; D014508:Urea / Q000378:metabolism
chemical_list: D014508:Urea